Research Alliance Corp III(RACC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 5 at 4:00 PM ET (Korea 11/6 06:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 29.66% | Shs Outstand | 7.8M | Perf Week | 0.59% |
| Market Cap | 0.09B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 6.4M | Perf Month | 0.1% |
| Enterprise Value | 0.09B | PEG | - | EPS next Q | - | Inst Own | 87.23% | Short Float | 0.14% | Perf Quarter | -59.03% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.11 | Perf Half Y | - |
| Sales | - | P/B | 1.25 | EPS next 5Y | - | ROA | - | Short Interest | 0.01M | Perf YTD | -0.49% |
| Book/sh | 8.13 | P/C | 111.37 | EPS past 3/5Y | - | ROE | - | 52W High | -69.67% ($33.50) | Perf Year | - |
| Cash/sh | 0.09 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 5.61% ($9.62) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 0.4% 0.72% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.23 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 17.3 | EPS Q/Q | - | Profit Margin | - | RSI (14) | 29.07 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 17.3 | Sales Q/Q | - | SMA20 | 0.17% ($10.14) | Beta | - | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | -17.34% ($12.29) | Rel Volume | 0.04 | Prev Close | $10.15 |
| Employees | - | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -25.44% ($13.63) | Avg Volume(3M) | 0.08M | Price | $10.16 |
| IPO | 2026/5/20 | Option/Short | No/Yes | Trades | 40 | Volume | 2,722 | Change | 0.1% |
🧬 Research Alliance III (RACC) is a US special purpose acquisition company (SPAC) formed to identify and combine with promising businesses in the biotechnology field by fully leveraging the sponsor group's expertise in bio venture capital and its healthcare network.
Over the past 1 year, on the lower side
70% below its 1-year high.
Traded less than usual. That is 4% of its average volume.
Company yardsticks do not fit here, so profitability, valuation and earnings are left out. The other verdicts still apply.
Long-term returns are roughly flat
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 87.2%.
Tap to view numbers
It ranks #1274 of 1436 in the industry
Based on market cap of $92M.
WTF#1270 Waton Financial Ltd $95M PER - RACC#1274 Research Alliance Corp III $92M PER - 
AUBN#1276 Auburn National Bancorp Inc $92M PER 10.6 
FDSB#1277 Fifth District Bancorp Inc $92M PER 53.8 
FAQ
What kind of company is RACC?
RACC belongs to the Financial sector and operates in the Shell Companies industry.
What is the market cap of RACC?
The market cap of RACC is approximately $92M, ranking 4,511 within its sector.
What is the 52-week high and low for RACC?
RACC has recorded a 52-week high of $33.50 and a low of $9.62.
